Vext Science, Inc. (VEXTF)
OTCMKTS
· Delayed Price · Currency is USD
0.1422
+0.0090 (6.79%)
Jul 3, 2025, 10:05 AM EDT
Vext Science Revenue
Vext Science had revenue of $11.56M in the quarter ending March 31, 2025, with 37.79% growth. This brings the company's revenue in the last twelve months to $39.17M, up 14.89% year-over-year. In the year 2024, Vext Science had annual revenue of $36.00M with 3.40% growth.
Revenue (ttm)
39.17M
Revenue Growth
+14.89%
P/S Ratio
1.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
40.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 84.04M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Vext Science News
- 13 days ago - Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield - Newsfile Corp
- 21 days ago - Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market - Newsfile Corp
- 4 weeks ago - Vext Announces Change of Auditor - Newsfile Corp
- 6 weeks ago - Vext Science, Inc. (VEXTF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue - Newsfile Corp
- 7 weeks ago - Vext to Announce Financial Results for Q1 2025 on May 21, 2025 - Newsfile Corp
- 3 months ago - Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License - Newsfile Corp
- 3 months ago - Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries - Newsfile Corp